Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:EndoCompass project : research roadmap for diabetes, obesity, and metabolism
Avtorji:ID Mathieu, Chantal (Avtor)
ID Meireles, Manuela (Avtor)
ID Pagotto, Uberto (Avtor)
ID Wabitsch, Martin (Avtor)
ID Banerjee, Indraneel (Avtor)
ID Bartolomé, Alberto (Avtor)
ID Battelino, Tadej (Avtor)
ID Dovč, Klemen (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,33 MB)
MD5: 3063197E48A823A0E8975FD5EC708918
 
URL URL - Izvorni URL, za dostop obiščite https://doi.org/10.1093/ejendo/lvaf065
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Background: Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At national funding level, endocrine societies report limited or little attention of national research funding towards endocrinology. The EndoCompass project—a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology, aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges. Methods: Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups. Results: Research priorities include: genetic/epigenetic factors, brain–periphery communication, and environmental influences. Key therapeutic areas include innovative approaches for monogenic disorders, incretin mimetics, dual receptor agonists, microbiome analysis, and improved behavioural interventions. For type 1 diabetes, priorities focus on early detection, insulin delivery systems, and disease-modifying therapies. Conclusions: This component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into diabetes and obesity pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of metabolic disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.
Ključne besede:EndoCompass, diabetes, obesity, funding, roadmap
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. ii47–ii71
Številčenje:Vol. 193, issue Supplement_2
PID:20.500.12556/DiRROS-27781 Novo okno
UDK:616.379
ISSN pri članku:1479-683X
DOI:10.1093/ejendo/lvaf065 Novo okno
COBISS.SI-ID:254623747 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 24. 10. 2025;
Datum objave v DiRROS:24.02.2026
Število ogledov:37
Število prenosov:18
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:European journal of endocrinology
Skrajšan naslov:Eur. j. endocrinol.
Založnik:Scandinavian University Press
ISSN:1479-683X
COBISS.SI-ID:521193753 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj